Bafna Pharmaceuticals Ltd

bafnapharma.com BSE: 532989 NSE : BAFNAPH
About [ edit ]

Bafna Pharmaceuticals is engaged in the Business of manufacture of pharmaceutical products.

Website BSE NSE
  • Market Cap ₹ 324 Cr.
  • Current Price ₹ 137
  • High / Low ₹ 234 / 10.2
  • Stock P/E
  • Book Value ₹ -1.79
  • Dividend Yield 0.00 %
  • ROCE -5.59 %
  • ROE -334 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Debtor days have improved from 151.40 to 51.82 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -15.16% over past five years.
  • Company has a low return on equity of -118.46% for last 3 years.
  • Company might be capitalizing the interest cost

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Jun 2019 Sep 2019
11.95 8.84 6.85 11.57
13.77 8.66 9.71 11.95
Operating Profit -1.82 0.18 -2.86 -0.38
OPM % -15.23% 2.04% -41.75% -3.28%
Other Income 0.09 -0.03 0.30 0.59
Interest 0.83 0.62 0.13 0.04
Depreciation 1.00 0.75 1.02 0.72
Profit before tax -3.56 -1.22 -3.71 -0.55
Tax % 1.12% -4.10% 42.59% -7.27%
Net Profit -3.52 -1.28 -2.13 -0.59
EPS in Rs -1.49 -0.54 -0.90 -2.49
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
129 175 185 97 85 65 46 44 42
110 153 162 117 85 71 81 57 41
Operating Profit 19 22 23 -20 1 -6 -35 -13 1
OPM % 15% 13% 12% -21% 1% -9% -77% -30% 3%
Other Income 1 3 2 46 2 1 31 1 -22
Interest 8 12 13 13 13 11 7 2 0
Depreciation 6 8 9 6 5 4 4 3 3
Profit before tax 5 5 2 6 -15 -20 -15 -17 -24
Tax % 64% 27% 42% -2% 1% 4% -15% -6% 0%
Net Profit 2 4 1 6 -14 -19 -17 -19 -25
EPS in Rs 1.00 2.12 0.75 3.31 -7.52 -10.23 -7.08 -7.98 -104.54
Dividend Payout % 0% 28% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years:%
5 Years:-15%
3 Years:-13%
TTM:-3%
Compounded Profit Growth
10 Years:%
5 Years:3%
3 Years:-11%
TTM:-31%
Stock Price CAGR
10 Years:12%
5 Years:35%
3 Years:77%
1 Year:573%
Return on Equity
10 Years:%
5 Years:-65%
3 Years:-118%
Last Year:-334%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions
Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
18 19 19 19 19 19 24 24 2
Reserves 40 46 50 53 39 20 14 -5 -7
Borrowings 85 100 108 69 80 82 47 46 3
76 96 59 59 54 57 54 54 73
Total Liabilities 219 261 236 200 193 178 138 119 71
76 73 69 55 53 49 45 37 35
CWIP 0 0 0 0 0 0 0 0 0
Investments 0 0 0 17 17 17 0 0 0
143 188 167 128 123 113 93 82 36
Total Assets 219 261 236 200 193 178 138 119 71

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
29 37 2 11 1 -1 -7 -2 -34
-38 -6 -7 60 -0 -5 38 15 33
-1 -12 -13 -71 -1 6 -31 -14 7
Net Cash Flow -9 19 -18 -0 -0 -0 0 -0 6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 11% 9% -12% -2% -7% -37% -22% -6%
Debtor Days 237 191 193 335 292 303 195 208 52
Inventory Turnover 5.67 5.31 3.85 4.22 3.26 2.95 3.04 2.19

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
26.36 26.36 26.36 26.36 26.36 26.36 26.36 26.40 26.40 92.64 92.64 91.74
73.64 73.64 73.64 73.64 73.64 73.64 73.64 73.60 73.60 7.36 7.36 8.26

Documents

Recent announcements


View all

Annual reports

Credit ratings